These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 9437567)
21. [The practice of electroconvulsive therapy: current contribution. II.--administration and evaluation of treatment]. Staner L Acta Psychiatr Belg; 1992; 92(1):33-48. PubMed ID: 1345420 [TBL] [Abstract][Full Text] [Related]
26. Electroconvulsive therapy for mood disorders in pregnancy. Bulut M; Bez Y; Kaya MC; Copoglu US; Bulbul F; Savas HA J ECT; 2013 Jun; 29(2):e19-20. PubMed ID: 23519218 [TBL] [Abstract][Full Text] [Related]
27. The effects of electroconvulsive therapy on ghrelin, leptin and cholesterol levels in patients with mood disorders. Kurt E; Guler O; Serteser M; Cansel N; Ozbulut O; Altinbaş K; Alataş G; Savaş H; Gecici O Neurosci Lett; 2007 Oct; 426(1):49-53. PubMed ID: 17884293 [TBL] [Abstract][Full Text] [Related]
28. Electroconvulsive therapy in patients with epilepsy. Lunde ME; Lee EK; Rasmussen KG Epilepsy Behav; 2006 Sep; 9(2):355-9. PubMed ID: 16876485 [TBL] [Abstract][Full Text] [Related]
29. The outcome of 369 ECT consultations. McCall WV; Dickerson LA J ECT; 2001 Mar; 17(1):50-2. PubMed ID: 11281516 [TBL] [Abstract][Full Text] [Related]
30. The use of electroconvulsive therapy in the elderly: a study from the psychiatric unit of a north Indian teaching hospital. Jain G; Kumar V; Chakrabarti S; Grover S J ECT; 2008 Jun; 24(2):122-7. PubMed ID: 18580554 [TBL] [Abstract][Full Text] [Related]
31. Safety of electroconvulsive therapy in patients with asthma. Mueller PS; Schak KM; Barnes RD; Rasmussen KG Neth J Med; 2006 Dec; 64(11):417-21. PubMed ID: 17179572 [TBL] [Abstract][Full Text] [Related]
32. The use of electroconvulsive therapy in geriatric patients. Greenberg L; Fink M Clin Geriatr Med; 1992 May; 8(2):349-54. PubMed ID: 1600484 [TBL] [Abstract][Full Text] [Related]
34. Achieving competency in electroconvulsive therapy: a model curriculum. Dolenc TJ; Philbrick KL Acad Psychiatry; 2007; 31(1):65-7. PubMed ID: 17242055 [TBL] [Abstract][Full Text] [Related]
35. Continuation electroconvulsive therapy for relapse prevention in middle-aged and elderly patients with intractable catatonic schizophrenia. Suzuki K; Awata S; Takano T; Ebina Y; Iwasaki H; Matsuoka H Psychiatry Clin Neurosci; 2005 Aug; 59(4):481-9. PubMed ID: 16048455 [TBL] [Abstract][Full Text] [Related]
36. Delayed sympathetic hyperactivity following electroconvulsive therapy in patients with catatonic schizophrenia. Kuwahara T; Yoshino A; Horikawa N; Nomura S Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Apr; 29(2):79-83. PubMed ID: 19562946 [TBL] [Abstract][Full Text] [Related]
37. [Ethical, legal and medical problems concerning ECT administration]. Zyss T Psychiatr Pol; 1995; 29(1):13-24. PubMed ID: 7878149 [TBL] [Abstract][Full Text] [Related]
38. Depressed patients perception of the efficacy of electroconvulsive therapy and venlafaxine therapy. Kopecek M; Cerná L; Sulak J; Raszka M; Bares M; Seifertová D Neuro Endocrinol Lett; 2007 Dec; 28(6):889-94. PubMed ID: 18063943 [TBL] [Abstract][Full Text] [Related]
39. Patients' perceptions of the process of consenting to electroconvulsive therapy. Fisher P; Johnstone L; Williamson K J Ment Health; 2011 Aug; 20(4):347-54. PubMed ID: 21770783 [TBL] [Abstract][Full Text] [Related]